Jeff Szer

Clinical Haematologist, marrow transplanter. Gaucher Disease and PNH expert. Past President WMDA and WBMT. Emeritus Editor-in-Chief Internal Medicine Journal.

[The IMJ @The_IMJ]

Closing the knowledge gap in diagnostic evaluation and treatment in Indigenous lung cancer care in the Northern Territory, Australia. https://t.co/8KoUEYNh8g #OpenAccess #OriginalArticle @TheRACP @WileyHealth

[SABMR @sabonemreg]

This World Marrow Donor Day – 22 September – we honour our #HopeHeroes.

To every selfless individual who registered and donated stem cells to save a life: thank you.

You are the reason hope lives on. 🧡

Join us in thanking donors worldwide.

#WMDD26 #HopeHero #ThankYouDonor

[The IMJ @The_IMJ]

Bone health in adults with non‐ambulatory neuromuscular disorders: a scoping review of risk factors, diagnosis and management https://t.co/vnYf4afFtu #OpenAccess #Review @TheRACP @WileyHealth

[The IMJ @The_IMJ]

CAC scoring is increasingly recognised as a non-invasive tool to refine cardiovascular risk assessment - however, clinical use remains inconsistent as recommendations across international & local guidelines vary. https://t.co/kgj4dUhZVZ #FreeAccess #Review @TheRACP @WileyHealth

[The IMJ @The_IMJ]

Diagnosis and treatment of idiopathic multicentric Castleman disease - an Australian clinical practice guideline. https://t.co/isi7innnhU #OpenAccess #PositionPaper @TheRACP @WileyHealth

[The IMJ @The_IMJ]

For the first time, read this paper to see an update on the results and outcomes of all intestinal transplants undertaken in Australia.
https://t.co/ZdbBA9ZuZi #OpenAccess #OriginalArticle @bc_diet @GutFailure @TheRACP @WileyHealth

[The IMJ @The_IMJ]

Where do paraneoplastic syndromes fit in the field of Neuro-oncology? The July editorial complements the Clinical Perspective 'Clinical approach to neurological paraneoplastic syndromes' by Anderson. https://t.co/9Y3zobWVZc #FreeAccess #Editorial #MedEd #Healthcare @WileyHealth

[The IMJ @The_IMJ]

The 2026 Australasian CLL Consensus Update—evidence-based guidance on diagnosis, treatment and supportive care for CLL across Australia and New Zealand. https://t.co/HLzzXjm1aF #CLL #BloodCancer #OpenAccess #PositionPaper @Jo_czerwinski @WileyHealth @PaulBridgmanMD @TheRACP

[The IMJ @The_IMJ]

Elevated serum osmolality reliably predicts patient-reported thirst, making osmolality-guided monitoring and tailored oral-care protocols essential for critical-care pathways. https://t.co/oK3VhncbbO #FreeAccess #Review @TheRACP @WileyHealth

[The IMJ @The_IMJ]

Diagnosing neurological paraneoplastic syndromes can be challenging as symptoms usually appear before a tumor is found. Accurate diagnosis relies on recognizing clinical phenotypes. https://t.co/ArqCZQFdhU #EditorsChoice #FreeAccess #ClinicalPerspective @TheRACP @WileyHealth

[The IMJ @The_IMJ]

IMJ August (Vol 56, Iss 8) is now online
https://t.co/HfnAwKi7km
@PaulBridgmanMD @TheRACP @WileyHealth @AndrewMallett8 @DanSteinfort @Russeldm @ianjohnwoolley2 @inglisjosh @les_sheffield @pkomesar @Badves @szetinglee1 @marrow

[Jeff Szer @marrow]

@Eddie_Cliff @CharlesJiangMD Best, most useful quote: “If I cannot open the raw file within seven days, the project does not exist yet. It is a rumor with a title.”

[The IMJ @The_IMJ]

A retrospective cohort study on the association between antipsychotics prior to and in the emergency department and their longer‐term impacts in older adults with acute agitation. https://t.co/BGv1i4jaiG #FreeAccess #OriginalArticle @PaulBridgmanMD @TheRACP @WileyHealth

[Jeff Szer @marrow]

#PNH You can catch up with our The Limbic webinar on Recent Advances in PNH with an Australian focus where I am joined by @SClugg and @drdannyhsu in an hour of discussion. @thelimbichaem

https://t.co/xyRMH1qpqr

[The IMJ @The_IMJ]

This month's editorial by @pkomesar questions current assumptions about peer review and draws attentions to the many challenges it presently faces. https://t.co/E7rflzjLVy #FreeAccess #Editorial #MedEd #HealthcareLeader @PaulBridgmanMD @WileyHealth

[Ezer Mizion @EzerMizionInc]

Entering the dark recesses of the soul of a #HolocaustSurvivor

https://t.co/2Wp79hw3E4

[The IMJ @The_IMJ]

Sjögren’s care is changing for the better. With Ianalumab's phase 3 success, new immune targets, and better tracking tools, lasting and patient-centred care is closer than ever. https://t.co/gHPi8mlrD9
#EditorsChoice #FreeAccess #Review @alberta_hoi @TheRACP @WileyHealth

[The IMJ @The_IMJ]

IMJ July (Vol 56, Iss 7) is now online
https://t.co/DmkG4l6poJ
@PaulBridgmanMD @TheRACP @WileyHealth @AndrewMallett8 @DanSteinfort @Russeldm @ianjohnwoolley2 @inglisjosh @les_sheffield @pkomesar @Badves @szetinglee1 @marrow

[The IMJ @The_IMJ]

CKD affects 1 in 10 Australians. This consensus recommendations provide actionable guidance for healthcare practitioners to improve CKD management across all levels of care in Australia.
https://t.co/xDj24RCMLf #OpenAccess #OriginalArticle @TheRACP @WileyHealth

[The IMJ @The_IMJ]

Ketogenic diet therapy is an effective non-drug treatment for drug-resistant epilepsy. Since PBS listing in 2009, annual spend has risen 21.6-fold, suggesting growing national use.
https://t.co/Txj4jTUZBV #OpenAccess #BriefCommunication @TheRACP @WileyHealth